Corrigendum to 'Level of MFAP4 in ascites independently predicts 1-year transplant-free survival in patients with cirrhosis' [JHEP Reports 3 (2021) 100287]

JHEP Rep. 2021 Aug 27;3(5):100353. doi: 10.1016/j.jhepr.2021.100353. eCollection 2021 Oct.

Abstract

[This corrects the article DOI: 10.1016/j.jhepr.2021.100287.].

Keywords: Biomarker; CLIF-C AD, CLIF Consortium Acute Decompensation; CPS, Child-Pugh score; CRP, C-reactive protein; CT, computed tomography; Decompensated; ECM, extracellular matrix; Fibrosis; GFR, glomerular filtration rate; HR, hazard ratio; INR, internationalised normal ratio; LTx, liver transplantation; Liver disease; MELD-Na, model for end-stage liver disease; MFAP4, microfibrillar associated protein 4; Mortality; NASH, non-alcoholic steatohepatitis; Prognosis; SBP, spontaneous bacterial peritonitis; eGFR, estimated GFR.

Publication types

  • Published Erratum